Italian contrast firm Bracco of Milan has completed its acquisition of E-Z-EM, a Lake Success, NY-based developer of gastrointestinal imaging and contrast injection products.
Bracco said the transaction was completed on April 1 at a price of $21 a share, with E-Z-EM becoming a wholly owned subsidiary of Bracco. The total value of the deal is more than $241 million.
In related news, Bracco's Acist Medical Systems business said it had acquired E-Z-EM's contrast delivery, contrast data management, and point-of-care testing business. Products offered by the business include the Empower line of contrast injector delivery systems, IRiS contrast management system, and EZ Chem chemistry device for testing serum creatinine levels.
Related Reading
E-Z-EM stockholders OK acquisition, March 21, 2008
Bracco to acquire E-Z-EM, October 30, 2007
Road to RSNA, MRI. E-Z-EM, October 29, 2007
Road to RSNA, CT, E-Z-EM, October 22, 2007
E-Z-EM sales dip in Q1, October 11, 2007
Copyright © 2008 AuntMinnie.com
